Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
You must be a Standard 1 Year member to access this content.
Cooley advised Courtside Ventures on the deal. Courtside Ventures, a top early-stage venture capital firm investing in companies across sports, gaming and lifestyle, announced its Fund III...
You must be a Standard 1 Year member to access this content.
Cooley advised Defy.vc on the deal. Defy.vc, an early-stage venture capital firm in Silicon Valley, announced its third fund at $300 million to invest in seed and...
You must be a Standard 1 Year member to access this content.
Cooley advised Cake Ventures on the deal. Cake Ventures, a pre-seed and seed stage venture capital firm, announced its $17 million first fund. Monique Woodard, founding partner...
You must be a Standard 1 Year member to access this content.
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Acceldata on the deal while Cooley advised Sanabil. Acceldata, the California-based market leader in data observability, announced its US$50 million Series C funding round. The...
You must be a Standard 1 Year member to access this content.
Heuking Kühn Lüer Wojtek and Cooley advised Conductor LLC on the deal. Conductor LLC, the leading platform in the field of Search Engine Optimization (SEO) for...
You must be a Standard 1 Year member to access this content.
Cooley advised Vision Ridge on the deal. Vision Ridge, an alternative asset manager focused on sustainable real assets, announced the closing of its SAF Annex Fund at...
You must be a Standard 1 Year member to access this content.
Cooley advised Logicworks on the deal. Logicworks, a high-growth managed cloud services company, announced its sale to Cox Communications, a private broadband provider. Logicworks will strengthen Cox’s...
You must be a Standard 1 Year member to access this content.
Cooley advised Angion on the deal. Angion, a clinical-stage biopharmaceutical company, announced its definitive merger agreement with Elicio Therapeutics. Elicio will merge with a wholly owned subsidiary...
You must be a Standard 1 Year member to access this content.
Cooley advised World View on the deal. World View, a leader in stratospheric exploration and flight, announced its definitive business combination agreement with publicly traded special purpose...
You must be a Standard 1 Year member to access this content.
Cooley advised Inscripta on the deal. Inscripta, a global leader in genome engineering technology, announced its acquisition of Infinome Biosciences and Sestina Bio. These acquisitions advance Inscripta’s...
You must be a Standard 1 Year member to access this content.
